Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Annals of Translational Medicine|September 21, 2020
Metabolic programming of tumor associated macrophages in the context of cancer treatmentThomas Crezee, Katrin Rabold, Lisanne de Jong, et al.Toxicology|August 31, 2024
There is no need for overnight fasting of rats in regulatory toxicology studiesShirley J A C Arnouts, Thomas Crezee, Kirsten C G Hartman-Van Dycke, et al.Endocrine Connections|October 28, 2020
Akt1 genetic variants confer increased susceptibility to thyroid cancerThomas Crezee, Mirela Petrulea, Doina Piciu, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 16, 2017
Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid CancerMarika H Tesselaar, Thomas Crezee, Imke Schuurmans, et al.Oncology Letters|June 21, 2021
IGF2 is a potential factor in RAI-refractory differentiated thyroid cancerThomas Crezee, Marika H Tesselaar, Martin Jaeger, et al.Molecular Cancer Therapeutics|November 13, 2016
Digitalis-like Compounds Facilitate Non-Medullary Thyroid Cancer Redifferentiation through Intracellular Ca2+, FOS, and Autophagy-Dependent PathwaysMarika H Tesselaar, Thomas Crezee, Herman G Swarts, et al.Cellular Oncology (Dordrecht, Netherlands)|February 3, 2021
Digoxin treatment reactivates in vivo radioactive iodide uptake and correlates with favorable clinical outcome in non-medullary thyroid cancerThomas Crezee, Marika H Tesselaar, James Nagarajah, et al.Pageof 1